The month of November is recognized around the world as Lung Cancer Awareness Month, a time to advocate and spread awareness about lung cancer. This form of cancer is not rare and is in fact the leading cause of cancer deaths in the US. The American Lung Association has a number of different initiatives this month that can help you play your part in spreading awareness about this disease.
The association’s Lung Force initiative aims to unite people that are impacted by the disease by supporting research, lung cancer education, and advocacy. If you are affected by the disease, then you can share your story with Lung Force.
Click here to learn more about it and submit your story.
Lung Cancer Screening
Screening at-risk groups for signs of cancer improves the chances of the disease being detected at an early stage. A major reason for low long-term survival in this disease is that it rarely inflicts noticeable symptoms in its early stages, resulting in late diagnosis. Click here to learn more about screening for lung cancer.
You can also get involved in spreading awareness this month by following the Lung Force on Facebook, X, and Instagram. They will be adding informative posts about the disease all month, so make sure to share the ones that resonate with you.
You can also contribute to the struggle against this cancer by supporting the American Lung Association monetarily. Click here to donate.
The organization is also working on its annual State of Lung Cancer Report, which is slated for release on November 14th. Keep an eye out and share it once it’s made public.
About Lung Cancer
There are multiple types of lung cancer. The disease is strongly linked to smoking cigarettes and other tobacco products, but exposure of the lung tissue to other toxic substances can also cause the disease. Other diseases and certain genetic conditions can also increase the risk of the disease. In some cases, no cause can be determined. Due to a lack of symptoms in early stages, the disease is often diagnosed at a late stage. Despite intensive treatment, the five-year-survival rate is low at around 15-20%. To learn more about lung cancer, click here.